UVA1 phototherapy for cutaneous diseases: An experience of 92 cases in the United States

Photodermatology Photoimmunology and Photomedicine

Volumn 22, Issue 5, 2006, Pages 247-253

  Tuchinda, Chanisada ^a   Kerr, Holly A ^a   Taylor, Charles R ^b   Jacobe, Heidi ^c   Bergamo, Bettany M ^d   Elmets, Craig ^d   Rivard, Jennifer ^a   Lim, Henry W ^a  

^a HENRY FORD HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Ohototherapy; UVA1

Indexed keywords

ANTIBIOTIC AGENT; CALCIPOTRIOL; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; PIMECROLIMUS; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; BURNING SENSATION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CUTANEOUS T CELL LYMPHOMA; DERMATITIS; ERYTHEMA; FEMALE; HUMAN; KELOID; LICHEN SCLEROSUS ET ATROPHICUS; LIPODERMATOSCLEROSIS; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INSTRUMENTATION; MEDICAL RECORD REVIEW; MORPHEA; NECROBIOSIS LIPOIDICA; NEPHROGENIC FIBROSING DERMOPATHY; PATIENT SAFETY; PHOTOTHERAPY; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUVA; RELAPSE; RIGIDITY; SCLERODERMA; SKIN COLOR; SKIN DISEASE; SYSTEMIC SCLEROSIS; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNITED STATES; URTICARIA PIGMENTOSA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; FOOT DERMATOSES; HAND DERMATOSES; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLEREDEMA ADULTORUM; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; UNITED STATES; URTICARIA PIGMENTOSA;

EID: 33748285230     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2006.00245.x     Document Type: Article

References (52)

1. Mutzhas MF, Holzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320-460nm: Physical description and dermatological applications. J Invest Dermatol 1981; 76: 42-47.
2. Krutmann J, Schopf E. High-dose-UVA1 phototherapy: A novel and highly effective approach for the treatment of acute exacerbation of atopic dermatitis. Acta Derm Venereol 1992; 176 (Suppl.):120-122.
3. Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schopf E. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-230.
4. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995; 346: 1166.
5. Scharffetter K, Wlaschek M, Hogg A, et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch Dermatol Res 1991; 283: 506-511.
6. Takeda K, Hatamochi A, Ueki H, Nakata M, Oishi Y. Decreased collagenase expression in cultured systemic sclerosis fibroblasts. J Invest Dermatol 1994; 103: 359-363.
7. Abeck D, Schmidt T, Fesq H, et al. Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. J Am Acad Dermatol 2000; 42: 254-257.
8. Kowalzick L. UVA1 for atopic dermatitis: Medium dose superior to low dose. J Am Acad Dermatol 2001; 44: 548.
9. Krutmann J, Diepgen TL, Luger TA, et al. High-dose UVA1 therapy for atopic dermatitis: Results of a multicenter trial. J Am Acad Dermatol 1998; 38: 589-593.
10. Grabbe J, Welker P, Humke S, et al. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996; 107: 419-422.
11. Camacho NR, Sanchez JE, Martin RF, Gonzalez JR, Sanchez JL. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001; 45: 697-699.
12. Gruss C, Stucker M, Kobyletzki G, Schreiber D, Altmeyer P, Kerscher M. Low dose UVA1 phototherapy in disabling pansclerotic morphoea of childhood. Br J Dermatol 1997; 136: 293-294.
13. de Rie MA, Enomoto DN, de Vries HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003; 207: 298-301.
14. Kreuter A, Breuckmann F, Uhle A, et al. Low-dose UVA1 phototherapy in systemic sclerosis: Effects on acrosclerosis. J Am Acad Dermatol 2004; 50: 740-747.
15. Kreuter A, Jansen T, Stucker M, et al. Low-dose ultraviolet-A1 phototherapy for lichen sclerosus et atrophicus. Clin Exp Dermatol 2001; 26: 30-32.
16. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: Results of a preliminary study. J Am Acad Dermatol 2002; 46: 251-255.
17. Grundmann-Kollmann M, Behrens S, Gruss C, Gottlober P, Peter RU, Kerscher M. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000; 42: 134-136.
18. Stander H, Schiller M, Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol 2002; 46: 799-800.
19. Schaller M, Romiti R, Wollenberg A, Prinz B, Woerle B. Improvement of cutaneous manifestations in POEMS syndrome after UVA1 phototherapy. J Am Acad Dermatol 2001; 45: 969-970.
20. Molina JF, McGrath H Jr. Longterm ultraviolet-A1 irradiation therapy in systemic erythematosus. J Rheumatol 1997; 24: 1072-1074.
21. Stege H, Schopf E, Ruzicka T, Krutmann J. High-dose UVA1 for urticaria pigmentosa. Lancet 1996; 347: 64.
22. Plotz SG, Abeck D, Seitzer U, Hein R, Ring J. UVA1 for hypereosinophilic syndrome. Acta Derm Venereol 2000; 80: 221.
23. Muchenberger S, Schopf E, Simon JC. Phototherapy with UV-A-I for generalized granuloma annulare. Arch Dermatol 1997; 133: 1605.
24. Mahnke N, Medve-Koenigs K, Berneburg M, Ruzicka T, Neumann NJ. Cutaneous sarcoidosis treated with medium-dose UVA1. J Am Acad Dermatol 2004; 50: 978-979.
25. Asawanonda P, Khoo LS, Fitzpatrick TB, Taylor CR. UV-A1 for keloid. Arch Dermatol 1999;135: 348-349.
26. Von KG, Kreuter JA, Nordmeier R, Stucker M, Altmeyer P. Treatment of idiopathic mucinosis follicularis with UVA1 cold light phototherapy. Dermatology 2000; 201: 76-77.
27. Pinton PC, Capezzera R, Zane C, De PG. Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002; 47: 410-414.
28. Zane C, Leali C, Airo P, De PG, Pinton PC. "High-dose"UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001; 44: 629-633.
29. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003; 148: 626-637.
30. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999; 112: 3-12.
31. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997; 186: 1763-1768.
32. Krutmann J. Phototherapy for atopic dermatitis. Clin Exp Dermatol 2000; 25: 552-558.
33. Petersen MJ, Hansen C, Craig S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J Invest Dermatol 1992; 99: 440-444.
34. Yin L, Yamauchi R, Tsuji T, Krutmann J, Morita A. The expression of matrix metalloproteinase-1 mRNA induced by ultraviolet A1 (340-400nm) is phototherapy relevant to the glutathione (GSH) content in skin fibroblasts of systemic sclerosis. J Dermatol 2003; 30: 173-180.
35. Von KG, Pieck C, Hoffmann K, Freitag M, Altmeyer P. Medium-dose UVA1 cold-light phototherapy in the treatment of severe atopic dermatitis. J Am Acad Dermatol 1999; 41: 931-937.
36. Kowalzick L, Kleinheinz A, Weichenthal M, et al. Low dose versus medium dose UV-A1 treatment in severe atopic eczema. Acta Derm Venereol 1995; 75: 43-45.
37. Jekler J, Larko O. Phototherapy for atopic dermatitis with ultraviolet A (UVA), low-dose UVB and combined UVA and UVB: Two paired-comparison studies. Photodermatol Photoimmunol Photomed 1991; 8: 151-156.
38. Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol 1998; 78: 318-319.
39. Grundmann-Kollmann M, Ochsendorf F, Zollner TM, Spieth K, Kaufmann R, Podda M. Cream PUVA therapy for scleredema adultorum. Br J Dermatol 2000; 142: 1058-1059.
40. Stables GI, Taylor PC, Highet AS. Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis. Br J Dermatol 2000; 142: 781-783.
41. Hager CM, Sobhi HA, Hunzelmann N, et al. Bath-PUVA therapy in three patients with scleredema adultorum. J Am Acad Dermatol 1998; 38: 240-242.
42. Janiga JJ, Ward DH, Lim HW. UVA-1 as a treatment for scleredema. Photodermatol Photoimmunol Photomed 2004; 20: 210-211.
43. Stege H, Berneburg M, Humke S, et al. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997; 36: 938-944.
44. Kerscher M, Volkenandt M, Gruss C, et al. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998; 38: 21-26.
45. Gruss CJ, Von KG, Behrens-Williams SC, et al. Effects of low dose ultraviolet A-1 phototherapy on morphea. Photodermatol Photoimmunol Photomed 2001; 17: 149-155.
46. El-Mofty M, Mostafa W, Esmat S, et al. Suggested mechanisms of action of UVA phototherapy in morphea: A molecular study. Photodermatol Photoimmunol Photomed 2004; 20: 93-100.
47. Breuckmann F, Stuecker M, Altmeyer P, Kreuter A. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res 2004; 296: 235-239.
48. Kafi R, Fisher GJ, Quan T, et al. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 2004; 140: 1322-1324.
49. Ziemer M, Thiele JJ, Gruhn B, Elsner P. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life. J Am Acad Dermatol 2004; 51: 318-319.
50. Hannuksela-Svahn A, Grandal OJ, Thorstensen T, Christensen OB. UVA1 for treatment of keloids. Acta Derm Venereol 1999; 79: 490.
51. Tzaneva S, Seeber A, Schwaiger M, Honigsmann H, Tanew A. High-dose versus medium-dose UVA1 phototherapy for patients with severe generalized atopic dermatitis. J Am Acad Dermatol 2001; 45: 503-507.
52. Wallenfang K, Stadler R. Association between UVA1 and PUVA bath therapy and development of malignant melanoma. Hautarzt 2001; 52: 705-707.